5. Turbo DNA-free DNase treatment and removal reagents
(Ambion).
6. oligo(dT) primer and SuperScript II reverse transcriptase (Life
Technologies).
7. Gene-specific primers for qPCR of beta-interferon [21] and
β-actin [37].
2.5.6 Vaccine Efficacy
Study
1. 12 Female BALB/c Mice.
2. Phosphate-buffered saline (PBS). (see Subheading 2.3.1, item
6) (see Note 1).
3. MA-WT virus, PR8, HK68-MA20C [33].
4. 10% formalin for fixation.
5. Monoclonal antibody against the NP (clone HB65; ATCC) of
influenza A virus.
2.5.7 Protein Expression
Studies Using Western
Blotting
1. 12% SDS–polyacrylamide gels.
2. Primary antibodies.
(a) PB2 (catalog number vN19; Santa Cruz).
(b) PB1 (catalog number F5-19; BEI Resources).
(c) PA (a generous gift from Ervin Fodor, University of
Oxford), HA (catalog number ab91531; Abcam).
(d) NP (catalog number C43; Abcam).
(e) NA (catalog number ab21304; Abcam).
(f) M1 (catalog number GA2B; Santa Cruz).
(g) NS1 (catalog number 23-1; Santa Cruz).
(h) β-actin (catalog number C4; Santa Cruz).
3. IRDye-conjugated secondary antibodies (LI-COR).
4. Odyssey CLx infrared imaging system.
2.6 Transposon
Mutagenesis [16]
2.6.1 Cell Culture
1. Cell line: HEK293T, MDCK cells.
2. DMEM.
3. 5% FBS.
4. Penicillin/streptomycin (100 U/mL and 50 μg/mL,
respectively).
5. 1 mM sodium pyruvate.
2.6.2 Generation of M
Gene Segment Mutant
Plasmid Library
and Functional Profiling
1. 15-nt sequence (5
0 -NNNNNTGCGGCCGCA-3
0 ; N ¼ duplicated 5 nucleotides from target DNA).
2. (MGS kit, Finnzymes).
3. E. coli DH10B.
4. ElectroMax DH10B, Invitrogen.
Live Vaccine Attenuation
337
Précédent

- 349/595

Suivant